Sign in
Canada Source-linked decisions Coverage checked

Canada Case Law

Search judgments by proposition, citation, court, judge or legal topic, then move directly into the source-grounded case analysis.

Courts on this page
2 court collections
Last checked

Canada decisions

Decisions matching the current search

Clear filters
Patent law 2025 FC 1725

Adeia Guides Inc. v. Videotron Ltd.

The Federal Court considered patent validity, claim construction, infringement, and remedies in a dispute between Adeia Guides Inc. and Videotron Ltd. over interactive television technologies.

  • Infringement
  • Validity
  • Claim construction
  • Anticipation
  • Obviousness
  • Double patenting
Read case analysis
Intellectual property 2025 FCA 134

AGI Suretrack, LLC v. Farmers Edge Inc.

The Court affirmed the Federal Court’s purposive construction limiting 'manufacturer code' and 'device class' to their ISO meanings, found those parameters and the microprocessor location to be essential based on the disclosure and lack of contrary expert evidence, held the CanPlug and FarmCommand did not include the essential ISO parameters so did not infringe, and concluded the '742 Patent is invalid because the GreenStar 3 anticipated the device claims and the remaining device and system claims were obvious in light of ISO and the common general knowledge; accordingly the appeals were dism…

  • Infringement
  • Anticipation
  • Obviousness
  • Claim construction
  • Essentiality
  • Costs
Read case analysis
Patent law 2025 FC 1078

McCain Foods Limited v. J.R. Simplot Company

The Federal Court construed key patent terms in McCain’s potato-processing patent, found Simplot’s PEF process outside the claims, and dismissed the action.

  • Claim construction
  • Infringement
  • Patent validity
  • Overbreadth
  • Utility (sound prediction)
  • Anticipation
Read case analysis
Patent law 2025 FC 754

Alexion Pharmaceuticals, Inc. v. Amgen Canada Inc.

Federal Court upheld Alexion’s 810 Patent, finding Amgen failed to prove anticipation or obviousness and granting infringement relief for BEKEMV eculizumab.

  • Anticipation
  • Obviousness
  • Claims construction
  • Injunction
  • Delivery up/destroy
  • Patent medicines (notice of compliance) regulations
Read case analysis
Patent law 2024 FCA 212

Steelhead LNG (ASLNG) Ltd. v. ARC Resources Ltd.

The Federal Court’s factual findings and credibility assessments supported its conclusions that the asserted claims were disclosed, anticipated or rendered obvious by the prior art; the appellants failed to show any palpable and overriding error or legal error in the Federal Court’s application of disclosure, anticipation and obviousness law, therefore the appeal is dismissed.

  • Anticipation
  • Obviousness
  • Disclosure/enablement
  • Claim construction
  • Standard of review
  • Costs
Read case analysis
Intellectual property 2024 FCA 156

Munchkin, Inc. v. Angelcare Canada Inc.

The Court dismissed Munchkin's appeal and upheld the Federal Court's findings on anticipation, obviousness and Munchkin, Inc.'s liability (noting a non-outcome-determinative error excluding Diaper Genie II from CGK). The Court allowed Angelcare's appeal: it concluded Munchkin's Generation 4 product infringes claims 9 and 10 of CA 2,640,384 and claims 1, 16, 17, 18, 19 and 20 of CA 2,855,159, amended the Federal Court judgment accordingly, and granted the permanent injunction and costs to Angelcare.

  • Anticipation
  • Obviousness
  • Claim construction
  • Infringement
  • Remedies
  • Confidential disclosure
Read case analysis
Intellectual property 2024 FC 1439

Proslide Technology, Inc. v. Whitewater West Industries, Ltd.

The Federal Court found no infringement of ProSlide’s asserted patents by WhiteWater’s AquaSphere, Orbiter, or Tailspin, and held several asserted claims invalid.

  • Patent infringement
  • Invalidity
  • Claim construction
  • Obviousness
  • Anticipation
  • Utility / sound prediction
Read case analysis
Patent law 2024 FCA 133

Agracity Crop & Nutrition Ltd. v. UPL NA Inc.

The Federal Court correctly held that the asserted claims of the 021 Patent were neither anticipated nor obvious: the cited prior patents did not disclose that flucarbazone sodium possessed the claimed selective herbicidal properties nor enable its claimed use (particularly for cereals/wheat), and the Federal Court applied the correct legal tests claim-by-claim and under the appropriate standard of review, so the appeals are dismissed.

  • Anticipation
  • Obviousness
  • Invalidity
  • Infringement
  • Costs
  • Disgorgement
Read case analysis
Intellectual property 2024 FC 1260

Molo Design, Ltd v. Chanel Canada Ulc

The Federal Court construed Molo’s patent for flexible partitions, found Chanel’s honeycomb paper products lacked the claimed supports, and held key claims invalid for anticipation or obviousness.

  • Claim construction
  • Infringement
  • Validity - anticipation
  • Validity - obviousness
  • Gillette defence
  • Costs
Read case analysis
Patent law 2024 FC 1198

Boehringer Ingelheim (Canada) Ltd. v. Jamp Pharma Corporation

Federal Court found the 083 Patent valid and infringed for nintedanib IPF use, but held the 267 Patent not infringed because lecithin was essential and absent from JAMP’s product.

  • Claims construction
  • Infringement
  • Inducement
  • Anticipation
  • Enablement
  • Sound prediction of utility
Read case analysis

About this LexChat collection

Canada decisions are organised by court, judge, legal area and indexed issue so a practitioner can move from a proposition to a citable authority with the surrounding context intact.